Development of transgenic rice seed accumulating a major Japanese cedar pollen allergen (Cry j 1) structurally disrupted for oral immunotherapy.
about
Concentrated protein body product derived from rice endosperm as an oral tolerogen for allergen-specific immunotherapy--a new mucosal vaccine formulation against Japanese cedar pollen allergyExpression of hypoallergenic Der f 2 derivatives with altered intramolecular disulphide bonds induces the formation of novel ER-derived protein bodies in transgenic rice seedsThe human immunodeficiency virus antigen Nef forms protein bodies in leaves of transgenic tobacco when fused to zeolin.Plant-based strategies aimed at expressing HIV antigens and neutralizing antibodies at high levels. Nef as a case studyThe use of rice seeds to produce human pharmaceuticals for oral therapy.Transgenic rice endosperm as a bioreactor for molecular pharming.Novel transgenic rice-based vaccines.The trafficking pathway of a wheat storage protein in transgenic rice endosperm.Expression pattern and activity of six glutelin gene promoters in transgenic rice.Recombinant protein yield in rice seed is enhanced by specific suppression of endogenous seed proteins at the same deposit site.Functional genomics of rice pollen and seed development by genome-wide transcript profiling and Ds insertion mutagenesis.Production of recombinant allergens in plants.Oral immunotherapy with transgenic rice seed containing destructed Japanese cedar pollen allergens, Cry j 1 and Cry j 2, against Japanese cedar pollinosis.Efficient recovery of recombinant proteins from cereal endosperm is affected by interaction with endogenous storage proteins.ER stress response induced by the production of human IL-7 in rice endosperm cells.Cellular Localization of Wheat High Molecular Weight Glutenin Subunits in Transgenic Rice Grain.Compensatory rebalancing of rice prolamins by production of recombinant prolamin/bioactive peptide fusion proteins within ER-derived protein bodies.Next generation immunotherapy for tree pollen allergies.Improving folate (vitamin B9) stability in biofortified rice through metabolic engineering.Deposition mode of transforming growth factor-β expressed in transgenic rice seed.
P2860
Q35182364-98C9CCF8-74D3-47EC-B6B0-E7AEB40B017EQ35955018-2858F0B7-0ACC-4B33-8655-42E77A405B9EQ36794088-DA17920D-B99D-49C4-9F0B-AFD418077FFCQ37377681-DC0BF48B-41F4-4CD1-85F3-6E5B9D35A7C5Q38149095-D1A0100B-CBA3-46F6-BB2C-4F0A0273712CQ38177654-9FE3A5BF-0079-441A-B378-3914C4D39AF7Q38229883-6C981007-C1B6-42C2-B025-154AFA52036AQ38394667-4A7E52B4-767F-4737-932E-E03D382147F4Q39033650-85167629-41EE-406D-A516-8094B4EA2D30Q39571255-9A6F2FD5-4470-4517-BD1F-9A354EB285ACQ41601113-9DE88587-948A-4B54-AD1F-80CCFC706708Q41956688-EF5581B7-BAD6-4AAC-BBC4-4C475C7A4393Q43560444-B51F0178-8448-4262-9B17-B7FCAFAE8BBAQ44704323-802F4992-E6A1-4664-8480-AB9402E18976Q45342855-FD1FAE42-5664-4B99-A392-2881C61BB002Q47157239-D0CF212E-2285-4670-8D8E-B3D2193DB030Q47597043-780FA67B-2ECD-46D2-ADD3-6E6B1851D620Q47884083-0A3E8C4B-C65B-4751-A500-1561AE2EADD6Q48131105-78C431BC-6E63-4CF5-9E59-6BD877A0A30EQ51540310-84BFDDBD-0E6E-49C8-B694-C953E0077FB6
P2860
Development of transgenic rice seed accumulating a major Japanese cedar pollen allergen (Cry j 1) structurally disrupted for oral immunotherapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Development of transgenic rice ...... rupted for oral immunotherapy.
@en
Development of transgenic rice seed accumulating a major Japanese cedar pollen allergen
@nl
type
label
Development of transgenic rice ...... rupted for oral immunotherapy.
@en
Development of transgenic rice seed accumulating a major Japanese cedar pollen allergen
@nl
prefLabel
Development of transgenic rice ...... rupted for oral immunotherapy.
@en
Development of transgenic rice seed accumulating a major Japanese cedar pollen allergen
@nl
P2093
P2860
P1476
Development of transgenic rice ...... rupted for oral immunotherapy.
@en
P2093
Fumio Takaiwa
Kazuya Suzuki
Lijun Yang
Sakiko Hirose
P2860
P304
P356
10.1111/J.1467-7652.2007.00287.X
P50
P577
2007-08-22T00:00:00Z